Credos Consulting Limited

CREDOS is the leading source of specialist technical expertise & consulting services for antibody and protein-based therapeutic discovery & development Founded in 2014, our consultants share very established track records in biotherapeutic drug discovery projects ‘at the coalface’, from project set-up to regulatory filing. Whether you are a start-up life science company, biotech or large pharma organisation, CREDOS is committed to support clients working in this specialist sector with world-leading expertise across all disciplines, when and for how long that support is needed. What consulting services can CREDOS offer? Many of the recent advances in medicine have come from antibody-based drugs. The discovery and development of biological therapeutics is a specialist activity requiring specific skills and experience. CREDOS is the only provider of specialist expertise for the discovery and development of therapeutic antibodies and other biologics. We offer a nose-to-tail specialist consultancy, working with clients across disciplines from early discovery to late development of biological therapeutics Our consulting services include- • Strategic leadership and technical expertise across all disciplines supporting the discovery & development of biotherapeutics.* • Development plans for a range of biotherapeutic projects including antibodies, recombinant proteins, novel-scaffolds, biosimilars, and where alternative routes of administration are needed. • Independent experts and consultants offering tailored solutions to address bespoke project needs, including derailed projects. • Virtual teams of experts to support and lead more complex or challenging projects including project management skills. • Due diligence opportunity/risk assessment. • Life cycle management of biologics portfolio. • Training to address gaps in drug discovery knowledge within your organisation, tailored to your specific needs.